Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin. | Expert Rev Clin Pharmacol | 2022 | 36065506 | PubTator, text mining | PubMed |
| 3D proximal tubule-on-chip model derived from kidney organoids with improved drug uptake. | Sci Rep | 2022 | 36056134 | PubTator, text mining | PubMed |
| Interrogation of T Cell-Enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine Metabolism. | Cancer Res Commun | 2022 | 36052016 | PubTator, text mining | PubMed |
| Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis. | Front Pharmacol | 2022 | 36046822 | PubTator, text mining | PubMed |
| TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review. | Front Pharmacol | 2022 | 36034781 | PubTator, text mining | PubMed |
| Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population. | J Antimicrob Chemother | 2022 | 36031789 | PubTator, text mining | PubMed |
| Placental imprinting of SLC22A3 in the IGF2R imprinted domain is conserved in therian mammals. | Epigenetics Chromatin | 2022 | 36030241 | PubTator, text mining | PubMed |
| Antiproliferative Copper(II) Complexes Bearing Mixed Chelating Ligands: Structural Characterization, ROS Scavenging, In Silico Studies, and Anti-Melanoma Activity. | Pharmaceutics | 2022 | 36015318 | PubTator, text mining | PubMed |
| Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response. | Pharmaceuticals (Basel) | 2022 | 36015138 | PubTator, text mining | PubMed |
| Issues Related to the Treatment of H. pylori Infection in People Living with HIV and Receiving Antiretrovirals. | Microorganisms | 2022 | 36013959 | PubTator, text mining | PubMed |
| Effect of Cisplatin on Renal Iron Homeostasis Components: Implication in Nephropathy. | ACS Omega | 2022 | 35990481 | PubTator, text mining | PubMed |
| Important roles of transporters in the pharmacokinetics of anti-viral nucleoside/nucleotide analogs. | Expert Opin Drug Metab Toxicol | 2022 | 35975669 | PubTator, text mining | PubMed |
| Reference intervals of urinary kidney injury biomarkers for middle-aged men and women determined by quantitative protein mass spectrometry. | Ann Clin Biochem | 2022 | 35957618 | PubTator, text mining | PubMed |
| MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. | Int J Mol Sci | 2022 | 35955741 | PubTator, text mining | PubMed |
| Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities. | Int J Mol Sci | 2022 | 35955563 | PubTator, text mining | PubMed |
| Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders. | Int J Mol Sci | 2022 | 35955427 | PubTator, text mining | PubMed |
| Potential Mechanisms Involved in Chronic Kidney Disease of Unclear Etiology. | Clin J Am Soc Nephrol | 2022 | 35944911 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis. | Sci Rep | 2022 | 35922447 | PubTator, text mining | PubMed |
| Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity. | Front Pharmacol | 2022 | 35910376 | PubTator, text mining | PubMed |
| Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis. | J Pharm Health Care Sci | 2022 | 35909131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=24